• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Insights on a mechanism to stop COVID-19 replication

Bioengineer by Bioengineer
November 19, 2020
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Just published the study of the Politecnico di Milano in the New Journal of Chemistry

IMAGE

Credit: Politecnico di Milano

Stopping the replication of SARS-CoV-2 is likely possible thanks to a compound called EBSELEN: a group of researchers from the Politecnico di Milano has communicated aspects relevant to the blocking of replication mechanism in the New Journal of Chemistry.

Two important aspects of the propagation of a virus are its ability to enter the host’s cells, that is, to infect the host, and then to replicate in infected cells.

As for SARS-CoV-2, the Mpro protein plays an important role in the replication and transcription of the virus. Mpro therefore represents a particularly promising target for blocking the virus itself because a compound that inhibits Mpro blocks the virus.

EBSELEN proved to be the most potent inhibitor of Mpro in a study examining approximately 10,000 selected compounds. In their study, the researchers at Politecnico elucidate key aspects of the Mpro blocking mechanism by EBSELEN.

“We have identified that the selenium atom of EBSELEN strongly interacts with some groups typically present in proteins via the chalcogen bond, a weak bonding that has been studied for years in our laboratories; this binding may contribute to the inhibition of the virus replication. This represents an important step forward in the fight against COVID-19. ” Says Prof. Giuseppe Resnati of the Department of Chemistry, Materials and Chemical Engineering “Giulio Natta” of the Politecnico di Milano.

The article clarifies the details of the EBSELEN / enzyme binding mechanism. It is shown that selenium plays a fundamental role in establishing the interactions that favor the binding of EBSELEN to SARS-CoV-2 and to other pathogenic retroviruses in humans such as those of HIV and Hepatitis C.

###

Media Contact
Cristina Perini
[email protected]

Original Source

https://pubs.rsc.org/en/content/articlelanding/2020/nj/d0nj04647g#!divAbstract

Tags: BiochemistryBiomedical/Environmental/Chemical EngineeringBiotechnologyCell BiologyMedicine/HealthMolecular BiologyPharmaceutical Sciences
Share12Tweet8Share2ShareShareShare2

Related Posts

CircMORC1 Loss Boosts Gastric Cancer Growth

CircMORC1 Loss Boosts Gastric Cancer Growth

August 13, 2025
Quantum Key Distribution Meets High-Speed Multi-Core Fiber

Quantum Key Distribution Meets High-Speed Multi-Core Fiber

August 13, 2025

Dopamine Signals Trigger Skin Invasion in Nematodes

August 13, 2025

Mentorship in Pediatric Radiology: Giving and Gaining

August 13, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    79 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    58 shares
    Share 23 Tweet 15
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

CircMORC1 Loss Boosts Gastric Cancer Growth

Quantum Key Distribution Meets High-Speed Multi-Core Fiber

Dopamine Signals Trigger Skin Invasion in Nematodes

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.